Companies: 49,247 Total Market Cap: 132679485458519.66

Genomma Lab Internacional, S.A.B. de C.V.

OTC-GNMLF
Healthcare Drug Manufacturers - Specialty & Generic
Rank #8865
Market Cap 1.08 B
Volume 5,000
Price 1.09
Change (%) 0.00%
Country or region Mexico Mexico

Genomma Lab Internacional, S.A.B. de C.V.'s latest marketcap:

1.08 B

As of 05/21/2025, Genomma Lab Internacional, S.A.B. de C.V.'s market capitalization has reached $1.08 B. According to our data, Genomma Lab Internacional, S.A.B. de C.V. is the 8865th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.08 B
Revenue (ttm) 920.59 M
Net Income (ttm) 108.51 M
Shares Out 0
EPS (ttm) 0.11
Forward PE 8.45
Ex-Dividend Date n/a
Earnings Date 04/23/2025
Market Cap Chart
Data Updated: 05/21/2025

Genomma Lab Internacional, S.A.B. de C.V.'s yearly market capitalization.

Genomma Lab Internacional, S.A.B. de C.V. has seen its market value grow from $957.93 M to $1.08 B since 2020, representing a total increase of 13.12% and an annual compound growth rate (CAGR) of 2.85%.
Date Market Cap Change (%)
05/21/2025 $1.08 B -2.59%
12/31/2024 $1.12 B 43.29%
12/29/2023 $778.50 M -9.87%
12/30/2022 $863.79 M -18.07%
12/31/2021 $1.05 B 10.06%
12/31/2020 $957.93 M

Company Profile

About Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V. is a leading pharmaceutical and personal care company headquartered in Mexico City, Mexico. Founded in 1996, the company operates both domestically and internationally, offering a diverse portfolio of branded healthcare and wellness products.

Product Portfolio

The company specializes in developing, selling, and marketing a wide range of products across multiple categories, including:

  • Anti-acne treatments & self-diagnosis solutions
  • Antibacterial & antifungal products
  • Skincare (scar improvement, anti-wrinkle creams)
  • Haircare (shampoos, dandruff treatments, anti-hair loss solutions)
  • Personal hygiene (soaps, razors)
  • Pain relief (muscle ointments, osteoarthritis treatments)
  • Digestive health (antacids, anti-ulcer, anti-colitic medications)
  • Cold & flu remedies
  • Hemorrhoid & varicose vein treatments
  • Ophthalmic medications
  • Infant nutrition products

With a strong presence in Mexico and expanding global reach, Genomma Lab Internacional continues to deliver high-quality healthcare solutions to consumers worldwide.

Frequently Asked Questions

As of 05/21/2025, Genomma Lab Internacional, S.A.B. de C.V. (including the parent company, if applicable) has an estimated market capitalization of $1.08 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Genomma Lab Internacional, S.A.B. de C.V. global market capitalization ranking is approximately 8865 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Mexico
Founded 1996
IPO Date n/a
Employees 1,633
CEO Juan Marco Sparvieri
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address Avenida Antonio Dovalí Jaime No. 70
Mexico City, 01210
Mexico
Website https://www.genommalab.com
People Also Watch
Zoetis
163.65 0.00%
Merck KGaA
132.41 0.00%
Haleon plc
548.39 0.00%
NSE-SUNPHARMA
19.96 0.00%